Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function 2022

Evaluation of acute adverse events after Covid-19 vaccination during pregnancy 2022

Early convalescent plasma for high-risk outpatients with Covid-19 2021

Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings 2021

Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine 2021

Cutaneous leishmaniasis 2020

Stolen breaths 2020

Metoprolol for the prevention of acute exacerbations of COPD 2019

Secondary surgical cytoreduction for recurrent ovarian cancer 2019

Vitamin D supplementation and prevention of type 2 diabetes 2019

Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC 2018

Effect of aspirin on all-cause mortality in the healthy elderly 2018

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly 2018

Effect of aspirin on disability-free survival in the healthy elderly 2018

Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC 2018

Angiotensin II for the treatment of vasodilatory shock 2017

Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer 2017

Liraglutide and renal outcomes in type 2 diabetes 2017

Intensive blood-pressure lowering in patients with acute cerebral hemorrhage 2016

Liraglutide and cardiovascular outcomes in type 2 diabetes 2016

Structural racism and supporting black lives - the role of health professionals 2016

High-cost generic drugs--implications for patients and policymakers 2014

Alogliptin after acute coronary syndrome in patients with type 2 diabetes 2013

Threshold-based insulin-pump interruption for reduction of hypoglycemia 2013

Azithromycin for prevention of exacerbations of COPD 2011

Long-term effects of intensive glucose lowering on cardiovascular outcomes 2011

Lung volumes and emphysema in smokers with interstitial lung abnormalities 2011

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes 2010

Effects of combination lipid therapy in type 2 diabetes mellitus 2010

Effects of intensive blood-pressure control in type 2 diabetes mellitus 2010

Effects of medical therapies on retinopathy progression in type 2 diabetes 2010

Effects of intensive glucose lowering in type 2 diabetes 2008

Executive physicals--bad medicine on three counts 2008

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus 2003

Inventing a new model of hypertension care for black men [editorial].  378. 2018

Romosozumab versus Alendronate and fracture risk in women with osteoporosis [editorial].  378. 2018

Access to essential medicines in the United States [editorial].  375. 2016

Essential medicines in the United States--why access is diminishing [editorial].  374. 2016

High-cost generic drugs--implications for patients and policymakers [editorial].  372. 2015

Threshold insulin-pump interruption to reduce hypoglycemia [editorial].  369. 2013

Collection of data on race and ethnic group by physician practices [editorial].  363. 2010

Insulin regimens in type 2 diabetes [editorial].  362. 2010

Hypereosinophilic syndrome and mepolizumab [editorial].  358. 2008

Management of acute hip fracture [review] 2017

Clinical practice. Vertebral fractures [review] 2011